Safety and Immunogenicity of a Trivalent Influenza Vaccine When Administered to Elderly Subjects

Clinical trial NCT01651104 · COMPLETED

Trial details

NCT number: NCT01651104
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Human Influenza

Start date: 2012-07-01
Primary completion: 2012-08-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.